Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

NCT04907149 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLPG3970 film-coated tablet
DRUG: [14C]GLPG3970 solution for infusion
DRUG: [14]GLPG3970 oral solution

Sponsor

Lakefront Biotherapeutics NV